But is it worth pushing to the maximum dose
However, these findings are not outcome claims, and researchers should treat retatrutide as a platform for studying how multiple hormonal inputs converge within complex metabolic systems
doi: 10.1016/j.bbrc.2019.01.103 49 BomfimTRForny-GermanoLSathlerLBBrito-MoreiraJHouzelJCDeckerHet al
Phase 2 trial results, published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023), demonstrated that participants receiving the highest dose of retatrutide lost an average of approximately 24% of their body weight over 48 weeks a finding that attracted considerable attention from the medical and scientific communities
American Journal of Psychiatry , 171(3), 276293
Microdosing allows treatment to be tailored to your bodys response